Search
for
Sort by
Research 61–90 of 464
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Ectrodactyly, Soft‐Tissue Syndactyly, and Nodulocystic Acne: Coincidence or Association?
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Common Topical Medications
- Drug eruptions in dermatology
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Persistent Papular Eruption in a Young Adult: Importance of Histopathology in Diagnosing Eruptive Vellus Hair Cysts
- Benign Cutaneous Eruptions After Transplantation
- Dermatologic Reactions to Targeted Therapy
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous drug reactions
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Efectos adversos dermatológicos con uso de litio
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Ingestion of a dietary supplement resulting in selenium toxicity
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Acne Syndromes and Mosaicism
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails